Both peptides show published activity across rodent and cell-culture tissue-repair models without binding a single canonical receptor, distinguishing the blend from receptor-targeted compounds
its administered via injections or capsules in clinical settings.[4] It enhances fat burning, energy, insulin sensitivity, muscle preservation, and repair, while indirectly boosting NAD+ by slowing depletion.[5][23][24] Its membrane-permeable nature allows efficient cellular entry, making it suitable for therapeutic use
Best case: a bubble wrap
Digestive issues may further reduce the effectiveness
confirm exact ratio per batch) Purity : High purity (9899% HPLC per component batch-specific COA available) Form : Lyophilized powder (co-lyophilized) Intended Use : For research purposes only Chemical Compounds in the Blend BPC-157 Chemical Name : Body Protection Compound-157 Sequence : Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula : CHNO Molecular Weight : ~1,794 Da Classification : Synthetic pentadecapeptide TB-500 (Thymosin Beta-4 fragment) Chemical Name : Thymosin Beta-4 active fragment Sequence : Ac-Lys-Lys-Thr-Glu-Thr-Gln (typical heptapeptide fragment) Molecular Formula : Varies by fragment (commonly referenced from Thymosin Beta-4) Molecular Weight : ~890 Da (for common fragment) Classification : Actin-sequestering peptide / regenerative fragment Research Background The BPC-157 + TB-500 blend is explored for complementary mechanisms: BPC-157 for localized tissue protection and healing, and TB-500 for systemic cytoskeletal organization, cell migration, and angiogenesis
Lancet Diabetes Endocrinol
